Bradley Alford - Perrigo Company Independent Director

PRGO Stock  USD 32.19  0.73  2.32%   

Director

Mr. Bradley A. Alford serves as Independent Director of the Company. Mr. Alford joined Advent International Corporationrationration, a global private equity firm, in 2014 as an Industry Advisor and moved to Operating Partner in March of 2016. From 2006 to 2013, Mr. Alford was Chairman and Chief Executive Officer of Nestl USA. Mr. Alford also served as CEO and President of Nestl Brands Company. He currently serves as a director of Avery Dennison Corporation since April 2010 and previously served as a director of Conagra Brands, Inc. from July 2015 to September 2018. Throughout his career, Mr. Alford was focused on developing brands, initiatives to improve processes and facilitate best practices across an organization. since 2017.
Age 64
Tenure 7 years
Phone353 1 709 4000
Webhttps://www.perrigo.com

Perrigo Company Management Efficiency

The company has return on total asset (ROA) of 0.0164 % which means that it generated a profit of $0.0164 on every $100 spent on assets. This is way below average. Perrigo Company's management efficiency ratios could be used to measure how well Perrigo Company manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 4.07 B in liabilities with Debt to Equity (D/E) ratio of 0.89, which is about average as compared to similar companies. Perrigo Company has a current ratio of 2.56, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Perrigo Company until it has trouble settling it off, either with new capital or with free cash flow. So, Perrigo Company's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Perrigo Company sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Perrigo to invest in growth at high rates of return. When we think about Perrigo Company's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

James FriedlichDHI Group
64
Jonathan ChadwickServiceNow
54
Scipio CarnecchiaDHI Group
58
Michael MaplesQ2 Holdings
75
Paul WhetsellBoyd Gaming
70
Charles GiancarloServiceNow
58
David GordonDHI Group
74
Patricia HatterQualys Inc
56
Carol CarpenterDHI Group
51
Kristi RogersQualys Inc
48
Golnar SheikholeslamiDHI Group
51
Paul ChamberlainServiceNow
56
Kathleen SwannDHI Group
58
Jeffrey DiehlQ2 Holdings
50
Jeffrey HankQualys Inc
58
Carl SchaperQ2 Holdings
66
John BaileyBoyd Gaming
60
Anita SandsServiceNow
43
William StraussServiceNow
56
Jeffrey BilbreyNetSol Technologies
43
Billy McCoyBoyd Gaming
73
Perrigo Company plc provides over-the-counter health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 9900 people. Perrigo Company PLC (PRGO) is traded on New York Stock Exchange in USA. It is located in The Sharp Building, Dublin, Ireland, D02 TY74 and employs 9,140 people. Perrigo Company is listed under Pharmaceutical Products category by Fama And French industry classification.

Management Performance

Perrigo Company Leadership Team

Elected by the shareholders, the Perrigo Company's board of directors comprises two types of representatives: Perrigo Company inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Perrigo. The board's role is to monitor Perrigo Company's management team and ensure that shareholders' interests are well served. Perrigo Company's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Perrigo Company's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Thomas Farrington, Executive Vice President, Chief Information Officer
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive Vice President, General Counsel, Company Secretary
Rolf Classon, Independent Chairman of the Board
Patrick LockwoodTaylor, CEO President
Raymond Silcock, Chief Financial Officer, Executive Vice President
Shlomo Yanai, Independent Director Nominee
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Mary ReillyBrest, Director Development
Murray Kessler, President, Chief Executive Officer, Director
Erica Mann, Independent Director
Kyle Hanson, General VP
Richard Sorota, Executive Vice President, General Manager - of Consumer Self-Care Americas
Gary Kunkle, Lead Independent Director
Katherine Doyle, Independent Director
Joseph Papa, Chairman and CEO
Catherine Schmelter, Executive Optimization
Bradley Alford, Independent Director
Alison Ives, Executive Officer
Jeffrey Smith, Independent Director
James Dillard, Executive Vice President, President - Consumer Self-Care Americas
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Orlando Ashford, Independent Director
Ronald Winowiecki, Acting CFO
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Shannon Hukill, Director Operations
Paul Weninger, Executive Vice President - Global Quality Operations
Herman Morris, Independent Director
Jatin Shah, Senior Vice President Chief Scientific Officer
Robert Willis, Chief Human Resource Officer, Executive Vice President
Theodore Samuels, Independent Director
Eduardo Bezerra, Executive CFO
Geoffrey Parker, Independent Director
Sharon Kochan, Executive Vice President, President - RX Pharmaceuticals
Marry Brlas, Independent Chairman of the Board
James III, Ex Americas
Bradley Joseph, Vice Communications
Ronald Janish, Executive Vice President - Global Operations and Supply Chain, Chief Transformation Officer
Uwe Rohrhoff, President CEO, Director

Perrigo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Perrigo Company a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Perrigo Company using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Perrigo Company offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Perrigo Company's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Perrigo Company Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Perrigo Company Plc Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Perrigo Company PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Perrigo Company information on this page should be used as a complementary analysis to other Perrigo Company's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Perrigo Stock analysis

When running Perrigo Company's price analysis, check to measure Perrigo Company's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perrigo Company is operating at the current time. Most of Perrigo Company's value examination focuses on studying past and present price action to predict the probability of Perrigo Company's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perrigo Company's price. Additionally, you may evaluate how the addition of Perrigo Company to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Is Perrigo Company's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Perrigo Company. If investors know Perrigo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Perrigo Company listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Perrigo Company is measured differently than its book value, which is the value of Perrigo that is recorded on the company's balance sheet. Investors also form their own opinion of Perrigo Company's value that differs from its market value or its book value, called intrinsic value, which is Perrigo Company's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Perrigo Company's market value can be influenced by many factors that don't directly affect Perrigo Company's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Perrigo Company's value and its price as these two are different measures arrived at by different means. Investors typically determine if Perrigo Company is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Perrigo Company's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.